Updates from the Exchange

Post written by Anja Lendvay, Clinical Operations Manager, Shacondra Johnson, Clinical Research Project Manager, and Emily Hoppes,...

Post written by Kate H. Rademacher, Kristine Torjesen, and Markus J. Steiner, FHI 360. This post originally appeared on the degrees blog....

Post written by Shana Abraham, Duke University student and intern at FHI 360 A year ago, decolonization was a concept I had only vaguely...

Our series on Beginning With the End In Mind continues this month with a celebration of Menstrual Hygiene Day, which is celebrated each...

Post written by Chastain Mann, WCG Cares and Ashley Jackson, PSI .This post originally appeared on the PSI Impact Blog. View the original...

Post written by Amelia Mackenzie, PhD ScM, FHI 360, and @AmesMack on Twitter Contraceptive product developers and funders alike have a...

Post written by Timothy D. Mastro, MD, DTM&H and Kavita Nanda, MD, MHS from FHI 360. This post originally appeared on the Knowledge...

How can we more effectively integrate considerations for acceptability, accessibility, affordability, and equity in contraceptive R&D?

“Beginning with the end in mind"; in the field of contraceptive research and development, we often use this phrase to highlight the...

Post written by Elizabeth Knippler, FHI 360 When I joined a team of researchers working in contraceptive technology in May 2020 through...

Post written by Male Contraceptive Initiative. This post originally appeared on MCI's website. View the original post here. Introduction...

How misperceptions of the manufacturing sector do no favours for contraceptive access Post written by Brian McKenna, Deputy Director,...